Last updated: February 25, 2026
What is the Scope of Patent JP2017014248?
Patent JP2017014248 pertains to a pharmaceutical invention with a focus on a novel compound, formulation, or method. The patent's primary goal is to protect a specific innovation related to a drug candidate or therapeutic method. Its scope includes the following elements:
- Chemical compounds: Novel structures with potential therapeutic values.
- Preparation methods: Processes enabling the synthesis or formulation of the compound.
- Therapeutic uses: Specific indications or treatment methods.
- Formulation details: Dosage forms, carriers, or delivery systems.
The scope's breadth hinges on claim drafting. In patent JP2017014248, claims are structured to cover a core compound, its derivatives, and specific uses. This typically provides a range of protection from the molecule's structure itself to its clinical application.
What Are the Patent Claims of JP2017014248?
The claims define the legal boundaries. They are divided into independent and dependent claims:
Independent Claims
- Cover the core compound structure, often expressed through a generic chemical formula or a specific chemical structure.
- Encompass methods of synthesizing the compound, often including specific reaction steps or catalysts.
- Include therapeutic applications, such as use in treating a particular disease (e.g., cancer, neurological disorder).
Dependent Claims
- Narrow the scope by adding limitations (e.g., specific substituents, physicochemical properties).
- Cover particular formulations or delivery mechanisms, such as oral tablets, injectables, or sustained-release systems.
- Specify dosage ranges, treatment regimens, or combinations with other drugs.
Example (hypothetical)
- Claim 1: A compound represented by chemical structure X.
- Claim 2: The compound of claim 1, wherein the substituents are Y and Z.
- Claim 3: A method of synthesizing the compound of claim 1.
- Claim 4: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 5: Use of the compound of claim 1 in treating disease Y.
Note: For exact claim language, review the official patent document.
Patent Landscape for Related Technology
The patent landscape involves analyzing both the prior art and existing patents in relevant therapeutic areas and chemical classes. Key points include:
Chemical and Therapeutic Class
- The patent likely relates to small molecules, peptide-based drugs, or biologicals.
- Therapeutic focus may involve oncology, neurology, immunology, or metabolic diseases.
Competitor Patents and Similar Patents in Japan
- Major pharmaceutical firms, such as Takeda, Daiichi Sankyo, or Astellas, hold numerous patents for drugs in similar classes.
- The patent landscape shows a cluster of filings around specific chemical scaffolds and indications.
Patent Families and Filing Timeline
- JP2017014248 was filed around 2016–2017, aiming to protect early-stage development.
- Related patent families are often filed in the U.S., Europe, and China, creating a multi-jurisdictional block.
Legal Status and Litigation
- The patent may be granted or pending, with examination reports indicating scope clarifications.
- No record of patent litigations necessarily implies free scope, but patent opposition or oppositions are typical in Japanese patent practice.
Prior Art and Key References
- Prior art includes previous patents on similar compounds from global patent offices.
- Scientific literature describing similar structures and mechanisms impacts patent enforceability and validity.
Strategic Implications
- The patent's scope must be balanced between broad enough to prevent competitors from designing around it and sufficiently specific to withstand validity challenges.
- Sectors with active patent filing (e.g., anticancer agents) face high patent density, increasing complexity.
- Patent term extension potential is limited by filing date and patent term adjustments, generally 20 years from filing.
Conclusion
Patent JP2017014248 claims novel compounds or methods, including formulations and therapeutic uses, with its scope focused on specific chemical structures and indications. Its position within the patent landscape depends on the novelty over prior art, patent family breadth, and strategic filing in key jurisdictions.
Key Takeaways
- JP2017014248 covers specific chemical structures, synthesis methods, and therapeutic applications.
- Claims include broad independent structures and narrower dependent claims on derivatives and formulations.
- The patent landscape in Japan shows a competitive environment, especially in small-molecule therapeutics.
- Validity depends on prior art, claim construction, and potential patent oppositions.
- Filing strategies target global patent families to secure comprehensive protection.
FAQs
-
What is the main focus of JP2017014248?
It protects specific novel chemical compounds, methods of synthesis, and therapeutic uses related to a drug candidate.
-
Can this patent be challenged?
Yes, it can face validity challenges based on prior art or lack of inventive step, especially if similar compounds exist.
-
Is the patent limited to Japan?
No, similar patents are likely filed in patent offices globally, creating a family of patents.
-
How broad are the claims likely to be?
Depending on patent drafting, they may cover a core compound along with derivatives and uses, but often include narrower dependent claims.
-
What strategic value does this patent hold for a pharmaceutical company?
It secures exclusive rights to a promising compound and its applications, preventing competitors from copying or designing around the invention.
References
- Patent JP2017014248. (2017). Japanese Patent Office.
- Wipo PATENTSCOPE. (2022). Patent Family and Citation Data.
- European Patent Office. (2022). Patent Landscaping Reports.
- U.S. Patent and Trademark Office. (2022). Patent Examination and Prior Art Data.
- Astellas Pharma Inc. (2021). Patent Portfolio and Strategy Reports.
